« Back
Phenotypic Cell-Based Screening of a High Content Imaging Cell Health Assay using the IN Cell Analyzer 2000
Phenotypic Cell-Based Screening of a High Content Imaging Cell Health Assay using the IN Cell Analyzer 2000
Submitted on 17 May 2016

Zaynab Neetoo-Isseljee, Chido Mpamhanga, David Tickle, Debra Taylor and Janet Brownlees
MRC Technology
This poster was presented at High Content & Phenotypic Screening 2016
Poster Views: 841
View poster »
Poster Abstract
Cell health assays play a key role in early drug discovery as they provide a crucial means of ranking novel chemical or biotherapeutic leads during screening and help to gain a better understanding of changes at the cellular level in disease pathologies. Recently there has been the emergence of High Content Screening (HCS), which integrates cell based imaging with multiple readouts in relevant cells in a high-throughput format. This has allowed in vitro cell health assays to be developed into High Content Imaging assays and used for HCS where they employ a multi-parametric approach enabling the capture of both phenotypic and mechanistic information of the cells. High Content Screening of cell health assays is now commonly being used as an early predictive toxicity assay to evaluate compound toxicity, in particular hepatotoxicity.
We demonstrate how we established an in-house cell health assay to be used for high content phenotypic screening using the IN Cell Analyzer 2000 with the aim to screen subsets of MRCT compound libraries and in-house compounds. The assay development process is illustrated using drugs withdrawn from the market or known to cause hepatotoxicity as tool compounds and initial screening of the FDA set in HepG2 cells to validate the assay. Genedata Screener analysis software was used for data processing and to visualise the data generated from the high content imaging screen.

O’Brien PJ, et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol. 80(9):580-604.Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Exploration of High-Temperature Petroleum Analysis Using Comprehensive Two=Dimensional Gas Chromatography and Time-of-Flight Mass Spectrometry
Christina Kelly, Joseph Binkley, Lorne Fell, David Alonso

Human iPSC-derived cardiomyocytes: A translational model to predict drug-induced cardiac arrhythmias and long-term toxicity
R Kettenhofen1, G Luerman1, R Bucerius1, I Kopljar2, DJ Gallacher2, A De Bondt2, E Vlaminckx2, I Van Den Wyngaert2, HR Lu2, H Bohlen1

Electrophysiological and cardiotoxicological characterization of human iPSC-derived cardiomyocytes (hiPSC-CMs) in 3D microtissues and 2D monolayers
Hortigon-Vinagre, Maria P. 1,2 ; Zamora, Victor1,2 ; Mamta Chabria3 ; Liudmila Polonchuk3 ; Bucerius, Roman4; Burton, Francis. L.1,2 ; Smith, Godfrey L.1,2

Mirror Therapy in management of Somatosensory impairment among post stroke hemiparesis
Vikas1*, Kamal Narayan Arya2*, Shanta Pandian3*, Dharmendra Kumar4*, Tinu Sethi5*

First Sunday Farmer’s Market: Addressing Nutritional Deficiencies Among Women 18-25 in Sulphur Springs
Freddy Cruz, Catherine Blackburn, Amanda McMahon, Takyah Smith, Bria Thomas

Keep up to date
with the latest posters
Receive World Wide Exposure
Increase Collaboration